Exchange: NASDAQ·Updated 04:01 AM EDT
AARD logo

AARD Aardvark Therapeutics Inc

$6.81
$0.00
(0.00%)
Pre-Market
Prev Close $6.81
Reported EarningsAug 11
Mkt Cap$158.67M
Vol1.00

About AARD

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
58

Bullish Sentiment

How do you feel about AARD?

Advertisement|Remove ads.